AstraZeneca agreed to pay $34 million to settle claims that the company paid kickbacks to improperly influence prescriptions paid for by Texas Medicaid.
The search for affordability wins is leading U.S. senators back to capping the cost of insulin at $35 in the private insurance market and for the uninsured
“There is a difference between a policy based on evidence and a broad legislative response that targets China-origin entities as inherently suspicious,” writes Brian Yang.
The Trump administration is moving to restart the specialized LGBTQ+ option for youth who contact the 988 crisis line, but the group that helped pioneer the idea is being shut…
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…
Medetomidine-laced opioids cause severe, life-threatening withdrawal in jails. Here's why many facilities remain ill-equipped to treat a growing crisis.
A new charter for the panel that advises the CDC on vaccine use substantially refocuses the responsibilities of the committee, downplaying its role in recommending the use of new vaccines.
Who got exclusive access to Eli Lilly's highly anticipated obesity candidate? And why are drugmakers spending so much on acquisitions? Find out on this week's "Readout LOUD."
The Supreme Court sided with the maker of Roundup weedkiller in a ruling expected to block thousands of lawsuits alleging it failed to warn people the product could cause cancer.
The use of genome editing in early embryos has pulled back the curtain on the role of one of the key genes that orchestrates the first stages of human development,…
It's an unusual time to be in the vaccine business. But in the view of those gathered at the BIO conference this week, it’s not altogether a bleak one.
“Women are fully capable of making difficult decisions, but meaningful choice requires trusted, vetted information,” writes Michelle Sie Whitten of the Global Down Syndrome Foundation.
A judge temporarily blocked federal prosecutors in Texas from getting access to the medical records of transgender patients treated at New York hospitals on Wednesday.
A clinical trial testing two drugs against the Bundibugyo ebolavirus, which is driving a fast-moving outbreak in Central Africa, is set to begin next week, WHO officials said.
A new study published in Nature uses artificial intelligence to identify people at high risk for sudden cardiac death, and pinpoints a possible reason.
The federal government can't block benefits from the nation's largest food aid program from being used to buy candy, soda, and other sugary drinks, a judge ruled.
The Justice Department has charged a Texas doctor in an $89 million health care fraud scheme, accusing him of billing insurers for medically unnecessary cardiovascular screening tests.
A new gene-editing startup negotiated contracts with a Chinese company, raised $230 million in funding, and executed a reverse-merger with a preexisting biotech company.
If the Supreme Court upholds the executive order ending birthright citizenship, it could “have stark consequences at the intersection of bioethics and public health.”
Exclusive: STAT has learned that Eli Lilly and the FDA allowed a 79-year-old to gain extraordinary access to an experimental obesity drug through the agency’s “compassionate use” program.
Pfizer said an experimental drug it hoped could replace a widely used chemotherapy in one of the most common forms of lung cancer fell short in a clinical trial.
Confirmed cases in the Ebola outbreak in eastern Congo have reached 1,003, including 254 deaths, officials said, as tracing those who had been in contact with patients remains a major challenge.
AbbVie is buying Apogee Therapeutics, the developer of an experimental atopic dermatitis drug, for nearly $11B, continuing a run of pharma acquisitions.
Definium Therapeutics said that its LSD therapy helped patients with major depression in its first Phase 3 trial, bringing the psychedelic drug closer to a potential approval.
The FDA will reconsider approving Regenxbio's experimental gene therapy for a deadly and rare childhood brain disorder it rejected just four months ago.
The psychiatric ER is “a detox center for those with no safe place to withdraw and a respite center for caregivers at their breaking point,” writes a psychiatrist.
Health disparities researchers say a new White House proposal could disqualify much of their work from federal funding — perhaps the most serious threat yet to the future of their…
Sanofi said that Paulo Fontoura, the chief medical officer at Xaira, would be taking over as its head of R&D, as the company tries to jumpstart its pipeline.
A panel of advisers to FDA gave its endorsement to a seasonal mRNA flu vaccine that was developed by Moderna and that earlier this year became the subject of controversy.
Making good on its threat, Eli Lilly has begun eliminating mandated price breaks to a few dozen hospitals that participate in a federal drug discount program.
